Human longevity biotech development plan (sequence) overview

Subscribe: Apple Podcasts | Google Podcasts | Spotify | RSS | More

One trend in humanity has been the average human lifespan increasing by multiple decades via the advances in medical biotech and food-production tech. I believe that the trend of the average human lifespan increasing will continue, via the further advances in medical biotech and the human longevity biotech.

I’ll keep on doing my own research in advancing medical biotech and developing the human longevity biotech.

In order to enable the human longevity biotech, I believe that medical biotech must advance futher to be able to cure the diseases that are currently incurable such as cancer; also, there has to be a biotech for de-aging or rejuvenating human bodies to enable humans to live longer with youthful and healthy human bodies.

A quick advertisement before I continue on this topic. You can invest in my startup company with as little as US$100, for supporting advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. Visit Robocentric.com/Investors to invest in my startup.

I’ve a multidecadal commitment to advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. To learn more about my cause, check out my books, which are available at Robocentric.com/Checkout, Amazon, Apple Books, Spotify, and other online audiobook retailers. Now, back to the main content.

Telomere and telomerase research is definitely on my high-priority items list, for developing cancer cure and the human longevity biotech or human-body deaging or rejuvenating biotech.

I see that certain sensor, scanner, biochemical analyzer and determiner, modeler, designer, synthesizer, and replacer biotech must be developed to advance medical biotech and the human longevity biotech. As I develop these core biotechnologies, I will also develop the human longevity biotech with intense and extensive research on human-body aging biomechanism and human-body anti-aging and deaging biotech.

I have a lot of work cut out for me in advancing biotech, with a multidecadal commitment. Thinking about the amount of work I plan to do in advancing science, technology, and capitalism over the next 30 to 40 years makes me feel dizzy and nauseous, because they are so humongous and gargantuan.

But I am commited to advancing biotech, especially the human longevity biotech, so I’ll keep on pursuing my commitment in advancing biotech, and see what happens.

You can invest in my startup company with as little as US$100, for supporting advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech. Visit Robocentric.com/Investors to invest in my startup.

My books on advancing AI, robotics, biotech, and nuclear-fusion powered outer space tech are available at Robocentric.com/Checkout, Amazon, Apple Books, Spotify, Google Play Store, and other online audiobook retailers.

I am Allen Young; I’m an Asian-American man who focuses on advancing AI, robotics, human longevity biotech, and nuclear-fusion powered outer space tech.